Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07751783
Recruiting
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
Not applicable · Taiwan · 1 site
Registry update: 7 Aug 2026
NCT07398300
Recruiting
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Not applicable · Denmark · 1 site
Registry update: 27 Oct 2026
2025-521205-41-00
Recruiting
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lymphoma
Phase 2 · Denmark · 6 sites
Registry update: 6 Nov 2026
NCT07520045
Recruiting
Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
Not applicable · Croatia · 1 site
Registry update: 9 Apr 2026
NCT07457528
Recruiting
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
Phase 2 · China · 1 site
Registry update: 11 Mar 2026
2025-524175-23-00
Recruiting
Impact of Early Thyroid Hormone Replacement on Kidney Function and Health-Related Quality of Life in Patients at Risk of Postoperative Hypothyroidism after Hemithyroidectomy: A Randomised Controlled Trial
Phase 4 · Denmark · 2 sites
Registry update: 3 Mar 2026
NCT07553754
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
Not applicable · China · 9 sites
Registry update: 28 Apr 2026
NCT07361510
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Phase 3 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Spain, Finland, France, United Kingdom, Hungary, India, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Romania, Sweden, Singapore, Thailand, Taiwan, United States · 273 sites
Registry update: 23 Oct 2026
NCT07241195
Recruiting
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
Not applicable · China · 1 site
Registry update: 1 Jun 2026
NCT07470151
Recruiting
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 13 Mar 2026
NCT07408531
Recruiting
LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)
Not applicable · United States · 2 sites
Registry update: 6 Aug 2026
NCT07339254
Recruiting
Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study
Not applicable · United States · 2 sites
Registry update: 16 Mar 2026
NCT07237594
Recruiting
IL-17 Blockade to Decrease irAEs (REPLAY)
Phase 1 · United States · 1 site
Registry update: 6 Nov 2026
NCT07336732
Recruiting
Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations
Phase 2 · China · 1 site
Registry update: 20 Mar 2026
NCT07144228
Recruiting
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Not applicable · United States · 1 site
Registry update: 4 Nov 2026
NCT07471776
Recruiting
Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Phase 2 · China · 1 site
Registry update: 13 Mar 2026
NCT07860528
Recruiting
Study on Prostate Salvage Using High-dose-rate Brachytherapy
Not applicable · Spain · 10 sites
Registry update: 9 Oct 2026
NCT07406659
Recruiting
Different Inspiratory Muscle Trainings in Patients With COPD
Not applicable · 1 site
Registry update: 16 Mar 2026
NCT06775964
Recruiting
Stem Cell Therapy for Early Alzheimer's Disease
Phase 1/2 · United States · 1 site
Registry update: 20 Apr 2026
NCT07287150
Recruiting
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 2 · Australia, Brazil, Canada, Germany, Spain, France, United Kingdom, Italy, South Korea, Mexico, Türkiye, United States · 55 sites
Registry update: 6 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.